NCT03550768

Brief Summary

Selective cannulation is an essential step for the success of ERCP. The successful cannulation is influenced by types of disease (such as Sphincter of Oddi Dysfunction and duodenal stricture), the experience of endoscopists and the anatomy of papilla. It is suggested that the size, morphology, orientation and location of major duodenal papilla (MDP), could cause a difficult cannulation (Endoscopy 2016; 48: 657-683). However, the related evidences are limited. The investigators hypothesized that special anatomy of papilla, such as a lanky shape (defined by the higher ratio of length to width) and a deeper location, could increase the difficulty of cannulation. Here the investigators investigated the effects of the anatomy of major duodenal papilla on post-ERCP pancreatitis and the procedure of cannulation in patients undergoing ERCP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
658

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 7, 2018

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 8, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2019

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
Last Updated

December 26, 2019

Status Verified

December 1, 2019

Enrollment Period

12 months

First QC Date

May 16, 2018

Last Update Submit

December 24, 2019

Conditions

Keywords

ERCPanatomy of major duodenal papilla

Outcome Measures

Primary Outcomes (1)

  • post-ERCP pancreatitis incidence

    frequency of post-ERCP pancreatitis

    48 hours

Secondary Outcomes (5)

  • Rate of difficult cannulation

    3 hours

  • Cannulation attempts

    3 hours

  • Total cannulation time

    3 hours

  • Unintended pancreatic duct cannulation

    3 hours

  • Complication rate

    48 hours

Study Arms (1)

MDP

ERCP was performed by trainees or trainers. Before the cannulation, the photo of major duodenal papilla will be taken carefully to evaluate its size, morphology, orientation and location. All patients initially received wire-guided cannulation with a sphincterotome, If cannulation failed, precut sphincterotomy or the double-wire technique was performed when appropriate. Therapeutic manipulation (eg, sphincterotomy, balloon dilation, stone extraction, and stenting) was done when appropriate. Pancreatic duct stent placement was performed at the discretion of the endoscopists.

Other: MDP

Interventions

MDPOTHER

evaluate the anatomy of each major duodenal papilla before selective cannulation during ERCP

MDP

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with native papilla who underwent ERCP

You may qualify if:

  • age 18-80
  • Patients with native papilla who underwent ERCP

You may not qualify if:

  • Prior endoscopic sphincterotomy
  • Minor pancreatic duct as the targeted duct
  • History of prior upper gastrointestinal surgery, such as Billroth I, II and Roux-en-Y
  • Fistula of MDP
  • Papillary carcinoma or adenoma
  • Duodenal obstruction, type II
  • Prior stent placement in common bile duct or pancreatic duct
  • Pregnant or breastfeeding women
  • Unwilling or inability to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of gastroenterology, Successful Hospital of Xiamen university

Xiamen, Fujian, 361001, China

Location

Huaihe Hospital of Henan University

Kaifeng, Henan, 475000, China

Location

Endoscopic center, Xijing Hospital of Digestive Diseases

Xi'an, Shaanxi, 710032, China

Location

Department of gastroenterology, Second Affiliated Hospital of Chongqing Medical University

Chongqing, 400010, China

Location

Related Publications (1)

  • Wang X, Zhao J, Wang L, Ning B, Zeng W, Tao Q, Ren G, Liang S, Luo H, Wang B, Farrell JJ, Pan Y, Guo X, Wu K. Relationship between papilla-related variables and post endoscopic retrograde cholangiopancreatography pancreatitis: A multicenter, prospective study. J Gastroenterol Hepatol. 2020 Dec;35(12):2184-2191. doi: 10.1111/jgh.15135. Epub 2020 Jun 29.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 16, 2018

First Posted

June 8, 2018

Study Start

May 7, 2018

Primary Completion

April 20, 2019

Study Completion

April 30, 2019

Last Updated

December 26, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations